Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:25 PM
Ignite Modification Date:
2025-12-24 @ 11:25 PM
NCT ID:
NCT01254656
Eligibility Criteria:
Inclusion Criteria:
* Patients must complete of 96 weeks of treatment with lersivirine (or comparator where required by local regulation) in one of the parent protocols (A5271015 or A5271022).
* Patients must have had a viral load less than 50 copies/mL at Week 84 of the parent protocol.
* For women who can have children, a negative urine pregnancy test at the Day 1 visit.
Exclusion Criteria:
* Patients with any Grade 4 Division of AIDS toxicity (except for lipids and asymptomatic glucose elevations will not be included in this trial.
* Patients being treated with another investigational product or in another clinical trial, except the lersivirine parent protocols will not be included in this trial.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01254656
Study Brief:
Protocol Section:
NCT01254656